Non-contrast Enhanced Cardiac Magnetic Resonance Normal Values and Imaging Protocols
Launched by MEDICAL UNIVERSITY OF GRAZ · Nov 13, 2012
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve and standardize cardiac magnetic resonance (MR) imaging techniques without using contrast agents, which are substances usually injected to enhance image quality. Researchers are looking to gather normal values for different heart imaging methods, focusing on how the heart looks and functions, including its size, blood flow, and the condition of the coronary arteries. This research will help ensure that cardiac MR images are accurate and reliable for diagnosing heart conditions in the future.
To participate in the trial, individuals must be between the ages of 65 and 74 and have no history of heart or lung diseases. They should also be able to give consent to participate. However, people with certain metal implants, those who are pregnant, or those who experience severe anxiety in confined spaces (claustrophobia) cannot take part. If eligible, participants can expect to undergo non-invasive MR imaging procedures, which are safe and painless, helping advance the understanding of heart health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • No history of cardiac or pulmonary diseases
- • ability to give informed consent
- Exclusion Criteria:
- • General MR exclusion criteria eg. patients with metal devices or other magnetic material in or on the subjects body which will be hazardous for MR investigation (e.g. heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants, coloured contact lenses, patch to deliver medications through the skin, any metal implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or any metal fragments or shrapnel in the body),
- • pregnancy,
- • claustrophobia.
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, Styria, Austria
Patients applied
Trial Officials
Ursula Reiter, PhD
Principal Investigator
Medical Unitersity Graz, Department of Radiology, Division of General Radiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials